Beijing Aier-Intech Eye Hospital, Beijing, 100021, China.
Department of Ophthalmology, Aier School of Ophthalmology, Central South University, Changsha, 410083, China.
BMC Ophthalmol. 2020 Jul 17;20(1):293. doi: 10.1186/s12886-020-01556-0.
With the difficulties in IOL power calculation and the potential side effects occurring postoperatively, multifocal IOL implantation after previous corneal refractive surgery are rarely reported especially for the trifocal IOL. Herein we report the clinical observation of trifocal IOL implantation in patients with previous myopia excimer laser correction. In this study, a multi-formula average method was performed for the IOLs power calculation to improve the accuracy. Visual and refractive outcomes were analyzed, and the subjective quality of patients' life was evaluated by questionnaires survey.
This retrospective case series included patients with previous myopia excimer laser correction who underwent femtosecond laser assisted phacoemulsification and trifocal IOL (AT LISA tri 839 MP) implantation. Follow-up was done at 1-day, 1-month and 3-month to assess the visual outcomes. Outcome measures were uncorrected distance, intermediate and near visual acuity (UDVA, UIVA, UNVA), manifest refraction, defocus curve, and subjective quality of vision.
Twenty-one Eyes from sixteen patients (14 eyes with previous laser in situ keratomileusis and 7 eyes with previous photorefractive keratectomy) were included. Mean postoperative spherical equivalent (SE) at 3-month was - 0.56 D ± 0.49 SD, wherein, 10 eyes (47.6%) were within ±0.50 D of the desired emmetropia and 19 eyes (90.5%) were within ±1.0 D. Mean monocular UDVA, UIVA and UNVA (logMAR) at last visit were 0.02 ± 0.07, 0.10 ± 0.10, and 0.15 ± 0.11 respectively. Three patients (19%) reported halos and glare in postoperative 3 months, two of them needed to use spectacles to improve the intermediate visual acuity. Fifteen patients (94%) reported a satisfaction score of ≥3.5 out of 4.0, without any difficulty in daily activity. Thirteen patients (81%) did not need spectacles at all distances, while the other 3 patients (19%) used spectacles for near-distance related visual activity. Mean composite score of the VF-14 questionnaire was 95.00 ± 7.29 out of 100.
Trifocal IOL implantation after myopia excimer laser correction could restore good distance, intermediate visual acuity and acceptable near visual acuity, and provide accurate refractive outcomes as well as high spectacles independence rate.
由于 IOL 屈光力计算困难以及术后可能出现的副作用,因此很少有报道多焦点 IOL 植入术在角膜屈光手术后,尤其是 trifocal IOL。在此,我们报告了三焦点 IOL 植入术在既往近视准分子激光矫正患者中的临床观察。在本研究中,我们采用了多种公式平均法进行 IOL 屈光力计算,以提高准确性。分析了视力和屈光结果,并通过问卷调查评估了患者生活质量。
本回顾性病例系列研究纳入了既往接受近视准分子激光矫正术的患者,这些患者接受了飞秒激光辅助超声乳化白内障吸除术和三焦点 IOL(AT LISA tri 839 MP)植入术。术后 1 天、1 个月和 3 个月进行随访,以评估视力结果。观察指标包括未矫正远视力(UDVA)、未矫正近视力(UNVA)、中间视力(UIVA)、最佳矫正视力(BCVA)、等效球镜(SE)、明视远点屈光力、离焦曲线和主观视觉质量。
16 例患者的 21 只眼(14 只眼既往行 LASIK,7 只眼既往行 PRK)被纳入研究。术后 3 个月平均等效球镜(SE)为-0.56 D ± 0.49 SD,其中 10 只眼(47.6%)在±0.50 D 的理想屈光范围内,19 只眼(90.5%)在±1.0 D 的范围内。末次随访时,13 例患者(81.3%)术后 3 个月远、中、近视力(logMAR)分别为 0.02 ± 0.07、0.10 ± 0.10、0.15 ± 0.11。3 例(19%)患者术后 3 个月出现光晕和眩光,其中 2 例需要戴镜改善中间视力。15 例(94%)患者报告的满意度评分≥4.0 分中的 3.5 分,无任何日常活动困难。13 例(81.3%)患者在任何距离均不需要戴镜,另外 3 例(19%)患者在近距离相关视觉活动时需要戴镜。VF-14 问卷的平均综合评分为 100 分中的 95.00 ± 7.29 分。
近视准分子激光矫正术后植入 trifocal IOL 可恢复良好的远、中视力和可接受的近视力,并提供准确的屈光结果和较高的不戴镜率。